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Available online 11 January 2016AbstractPurpose: To report a case of cytomegalovirus (CMV) retinitis in an immunocompetent adult patient.
Methods: A 61-year-old woman with proven CMV retinitis and no evidence of HIV or other underlying immunodeficiencies was referred.
Results: She was referred with history of recent right eye visual loss. In fundus examination, she had signs of retinal vasculitis. After initial
examination, she was found to have CMV retinitis documented by polymerase chain reaction (PCR) analysis of vitreous sample. She had neither
underlying risk factor in any assessed work-up nor any concomitant disease in 10 months follow-up. She received intravitreal ganciclovir with
good response to treatment.
Conclusion: Ophthalmologists should take into account infectious causes of retinal vasculitis before approaching anti-inflammatory or anti-
VEGF therapy.
Copyright © 2015, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Most cases of Cytomegalovirus (CMV) retinitis are re-
ported in acquired immunodeficiency syndrome (AIDS) pa-
tients.1 It can also affect other immunocompromised patients.1
Few cases are reported in healthy individuals.1 Here we pre-
sent a documented case of CMV retinitis in an otherwise
healthy patient.Case report
A 61-year-old woman was referred to our clinic with a 1-
month history of decreased vision in her right eye. Her best
corrected visual acuity was 4/20 in her right eye and hand
motion in the left eye. Examination of her right eye revealed
fine keratic precipitates, þ1 aqueous cells, mild vitritis,
patches of hemorrhagic retinitis with vessel segmentation, and* Corresponding author.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).perivascular sheathing along arcades with extension to fovea
(Fig. 1). There were few pigments in vitreous. In the left eye,
the patient had an old standing inferior rhegmatogenous retinal
detachment (RRD) (Figs. 2 and 3), optic disc pallor and
occluded vessels. Six months before her referral to our hos-
pital, she had received three injections of intravitreal bev-
acizumab (IVB) in her left eye with diagnosis of branch retinal
vein occlusion (BRVO). She had no history of systemic or
ocular disease nor any drug consumption.
She had been visited by other ophthalmologists and was
supposed to have retinal vaso-occlusive disease. Major neck
vessels were evaluated by doppler sonography to rule out
embolic obstruction of retinal vessels. The vessels were
normal. They consulted us for continuing treatment with IVB
injection.
Because of atypical feature of fundus, we suspected other
etiologies of retinal vasculitis. Complete Blood Count (CBC),
Erythrocyte Sedimentation Rate (ESR), Venereal Disease
Research Laboratory (VDRL), Fluorescent Treponemal Anti-
body Absorption (FTA-ABS), Purified Protein Derivative
(PPD), Anti Nuclear Antibodies (ANA), Rheumatoid Factorsting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
Fig. 1. CMV retinitis (OD) at baseline. Fig. 3. Left eye inferior detachment.
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chest X-ray, anti-HIV antibody, and PCR of vitreous sample
for CMV, Herpes Simplex Virus (HSV), Varicella Zoster Virus
(VZV) were the laboratory tests requested. They were all
normal except for a high concentration of CMV DNA in vit-
reous PCR (7,000,000 copy/ml) (QS-RGQ kit by Qiagen
company, Germany). PCR was negative for HSV and VZV
DNA. Patient's CD4 count was also normal (950 cells/mm3).
We requested an infectious and internal specialist consultation
with suspicion of an underlying immunodeficiency, malig-
nancy, or rheumatologic disorder (especially behcet's disease),
but all the work-ups including pathergy test and HLA-B51
were negative.
We administered intravitreal ganciclovir (2 mg) twice per
week as the loading dose for 2 weeks and then once per week.
Also oral valganciclovir (900 mg, BID) was prescribed. After
4 sessions of injection, the patient had substantial subjective
improvement in VA. Her BCVA improved to 8/20, and patches
of retinitis began to fade from the macula (Fig. 4). We
continued weekly injections for 2 months until resolution of
retinitis.Fig. 2. Left eye fundus view showing disc pallor and occluded vessels.Patient was offered RD surgery on her left eye, but she
refused to do it. Ten months after treatment, she had no new
sign of CMV reactivation.
Discussion
CMV infection is common worldwide. It is estimated that
40e100% of people are seropositive until the 4th decade of
life.2 Following primary infection virus spreads hema-
togenously and can infect the retina.3 CMV retinitis is the
most common opportunistic viral infection in HIV patients.4 It
occurs usually as CD4 count decreases below 50/mm3.4 It is
also seen in immunocompromised patients like lymphoma,
acute leukemia, and organ transplantation patients.5
It is quite unlikely to encounter CMV retinitis in immu-
nocompetent patients. There are few reports of CMV retinitis
in otherwise healthy patients. Gupta S et al6 reported nine
cases that were immunocompetent at the time of diagnosis.
Alaa Radwan et al5 also reported 2 cases of CMV retinitis that
were immunocompetent. In most reports, patients were limited
to those who had undergone intravitreal injection ofFig. 4. Fundus (OD) view after 4sessions of intravitreal gancyclovir in 2
weeks.
Fig. 5. OCT of patient's left eye 6 months before involvement of right eye.
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immunosuppression caused by intraocular injection.1,12
We have followed our patient for more than 10 months and
performed all the necessary laboratory tests, and no predis-
posing factor was found.
We did not perform diagnostic sampling of the left eye vit-
reous, but fundus occluded vessels (Fig. 2) and OCT picture of
this eye before her referral to our hospital (Fig. 5) may propose
prior CMV retinitis in the left eye that has lead to RRD. Retinal
detachment may occur in up to 24% of CMV retinitis patients.13
Most reports of successful treatment were in HIV positive
or immunocompromised patients. Induction and maintenance
therapy with intravenous ganciclovir, foscarnet and cidofovir
is efficacious but systemic side effects limit their use. Oral
valganciclovir is also effective with considerably less side
effects. Intravitreal injection of ganciclovir or cidofovir is an
effective alternative treatment that can bypass systemic side
effects with the same efficacy as systemic drugs. If recovery of
the patient's immune system is not possible, anti-CMV therapy
should be continued.14,15
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